{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:22:41Z","timestamp":1779333761840,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["19TPA34830061"],"award-info":[{"award-number":["19TPA34830061"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX000105"],"award-info":[{"award-number":["CX000105"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001048"],"award-info":[{"award-number":["CX001048"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL149719"],"award-info":[{"award-number":["HL149719"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bbrc.2021.02.145","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:25:24Z","timestamp":1617150324000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identification of novel pregnane X receptor (PXR) agonists by In silico and biological activity analyses and reversal of cigarette smoke-induced PXR downregulation"],"prefix":"10.1016","volume":"555","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-6018","authenticated-orcid":false,"given":"Rajan T.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-4607","authenticated-orcid":false,"given":"Toru","family":"Nyunoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.02.145_bib1","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.3390\/ijerph10094454","article-title":"Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review","volume":"10","author":"Kleinstreuer","year":"2013","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.bbrc.2021.02.145_bib2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm6738a7","article-title":"Current tobacco smoking, quit attempts, and knowledge about smoking risks among persons aged >\/=15 Years - global adult tobacco survey, 28 countries","volume":"67","author":"Ahluwalia","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.bbrc.2021.02.145_bib3","doi-asserted-by":"crossref","first-page":"2444S","DOI":"10.1093\/jn\/133.7.2444S","article-title":"The nuclear pregnane X receptor regulates xenobiotic detoxification","volume":"133","author":"Kliewer","year":"2003","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.bbrc.2021.02.145_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.102.038208","article-title":"Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells","volume":"304","author":"Hukkanen","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2021.02.145_bib5","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3892\/mmr.2016.5898","article-title":"Glucocorticoid receptor contributes to the altered expression of hepatic cytochrome P450 upon cigarette smoking","volume":"14","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2021.02.145_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2021.02.145_bib7","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1210\/en.2016-1559","article-title":"Visualizing the architectures and interactions of nuclear receptors","volume":"157","author":"Khorasanizadeh","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2021.02.145_bib8","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity","volume":"292","author":"Watkins","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2021.02.145_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1517\/17425255.2.6.847","article-title":"Pregnane X receptor and natural products: beyond drug\u2013drug interactions","volume":"2","author":"Staudinger","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1124\/dmd.108.020701","article-title":"A\u00a0comprehensive in\u00a0vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine","volume":"36","author":"Yasuda","year":"2008","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.bbrc.2021.02.145_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1124\/dmd.107.018341","article-title":"Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression","volume":"36","author":"Svecova","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2021.02.145_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/mol.64.2.474","article-title":"The environmental pollutant 1, 1-dichloro-2, 2-bis (p-chlorophenyl) ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor","volume":"64","author":"Wyde","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.02.145_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.drudis.2014.11.011","article-title":"Targeting xenobiotic receptors PXR and CAR in human diseases","volume":"20","author":"Banerjee","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2021.02.145_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/17425255.2012.685237","article-title":"Role of CAR and PXR in xenobiotic sensing and metabolism","volume":"8","author":"Wang","year":"2012","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrc.2021.02.145_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/mol.107.038398","article-title":"Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites","volume":"72","author":"Ekins","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000594","article-title":"Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR","volume":"5","author":"Ekins","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A\u00a0pharmacophore for human pregnane X receptor ligands","volume":"30","author":"Ekins","year":"2002","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.bbrc.2021.02.145_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/mol.108.049437","article-title":"Computational discovery of novel low micromolar human pregnane X receptor antagonists","volume":"74","author":"Ekins","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cbi.2010.09.018","article-title":"Rational quantitative structure\u2013activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands","volume":"188","author":"Dring","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2021.02.145_bib22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/tx800102e","article-title":"Machine learning methods and docking for predicting human pregnane X receptor activation","volume":"21","author":"Khandelwal","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.106.027623","article-title":"In silico prediction of pregnane x receptor activators by machine learning approached","volume":"71","author":"Ung","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.02.145_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2021.02.145_bib25","first-page":"1325","article-title":"Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes","volume":"29","author":"Drocourt","year":"2001","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.bbrc.2021.02.145_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-291X(02)00196-1","article-title":"Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response","volume":"293","author":"Beigneux","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.02.145_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr. Rev."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21003727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21003727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:23:41Z","timestamp":1778639021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21003727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"alternative-id":["S0006291X21003727"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.145","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel pregnane X receptor (PXR) agonists by In silico and biological activity analyses and reversal of cigarette smoke-induced PXR downregulation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}